Last month, 22 women won a legal case alleging Johnson & Johnson’s talcum powder led to the development of ovarian cancer. The result of the talcum powder cancer case, awarding $4.69…
For decades, women have unknowingly faced talcum powder cancer risks related to widely used cosmetic and hygiene products. Now, armed with knowledge and support, they’re fighting back – and winning – in…
Ovarian Cancer Drug Developments A once-daily pill called Niraparib has been approved in the U.K. after studies found it can add an extra 16 months to an ovarian cancer patient’s life…
Surgical Mesh Devices Abroad Slow Response to Mesh Injuries Worries NZ Health Minister Problems with surgical mesh have arisen across the pond. New Zealand’s Minister of Health, David Clark, met with…
A recent $417 million verdict, awarded to California ovarian cancer patient Eva Echeverria, was considered a victory for the hundreds of women who used Johnson & Johnson’s Baby Powder. Researchers have…
